Will Next Spending Bill Make Generic Drugmakers Happy?

March 7, 2018

Bipartisan House and Senate lawmakers are pushing for legislation that would stop branded drug companies from using Food and Drug Administration (FDA)-mandated risk plans to block generic competition to be added to the omnibus spending bill.

Related Stories